CAS: 115900-75-9; Cgp 46700

合成参考文献

参考文献:10.1016/s0162-0134(99)00029-x
摘要:Desroches S, Biron F, Berthon G. Aluminum speciation studies in biological fluids. Part 5. A quantitative investigation of A1(III) complex equilibria with desferrioxamine, 2,3-dihydroxybenzoic acid, Tiron, CP20 (L1), and CP94 under physiological conditions, and computer-aided assessment of the aluminum-mobilizing capacities of these ligands in vivo. J Inorg Biochem. 1999 May 30;75(1):27–35. doi: 10.1016/s0162-0134(99)00029-x.
参考文献:10.1016/0003-9861(92)90687-r
摘要:Hartley A, Rice-Evans C. The chelation of nonheme iron within sickle erythrocytes by the hydroxypyridinone chelator CP094. Archives of Biochemistry and Biophysics. 1992 Sep;297(2):377–82. doi: 10.1016/0003-9861(92)90687-r.
摘要:Hoyes KP, Hider RC, Porter JB. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines. Cancer Res. 1992 Sep 01;52(17):4591–9.
参考文献:10.1021/jm00030a005
摘要:el-Jammal A, Howell PL, Turner MA, Li N, Templeton DM. Copper complexation by 3-hydroxypyridin-4-one iron chelators: structural and iron competition studies. J Med Chem. 1994 Feb 18;37(4):461–6. doi: 10.1021/jm00030a005.
参考文献:10.1182/blood.v89.3.1045
摘要:Smith AG, Clothier B, Francis JE, Gibbs AH, De Matteis F, Hider RC. Protoporphyria Induced by the Orally Active Iron Chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn Mice. 1997 Feb 01;89(3):1045–51. doi: 10.1182/blood.v89.3.1045.